P W Collins1, R Cannings-John2, D Bruynseels3, S Mallaiah4, J Dick5, C Elton6, A D Weeks7, J Sanders8, N Aawar2, J Townson2, K Hood2, J E Hall9, R E Collis3. 1. Institute of Infection and Immunity, School of Medicine Cardiff University, UK. 2. Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, UK. 3. Department of Anaesthetics and Pain Control, Cardiff and Vale University Health Board, UK. 4. Tom Byson Department of Anaesthesia, Liverpool Women's Hospital, Liverpool, UK. 5. Department of Anaesthetics, University College Hospital London, UK. 6. Department of Anaesthetics, Leicester Royal Infirmary, Leicester, UK. 7. Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. 8. School of Healthcare Sciences, Cardiff University, Cardiff, UK. 9. Department of Anaesthetics and Pain Control, School of Medicine Cardiff University, Heath Park, UK.
Abstract
BACKGROUND: Postpartum haemorrhage (PPH) can be exacerbated by haemostatic failure. We hypothesized that early fibrinogen replacement, guided by viscoelastometric testing, reduces blood product usage and bleed size. METHODS: Women with PPH 1000-1500 ml were enrolled. If Fibtem A5 was ≤15 mm and bleeding continued, subjects were randomized to fibrinogen concentrate or placebo. The primary outcome compared the number of units of red blood cells, plasma, cryoprecipitate and platelets transfused. RESULTS: Of 663 women enrolled 55 were randomized. The adjusted incidence rate ratio (IRR) (95% CI) for the number of allogeneic units transfused in the fibrinogen group compared with placebo was 0.72 (0.3-1.7), P =0.45. In pre-specified subgroup analyses, subjects who had a Fibtem A5 ≤12 mm at the time of randomization and who received fibrinogen concentrate received a median (25th-75th centile) of 1 (0-4.5) unit of allogeneic blood products and had an additional 300 (100-350) ml blood loss whereas those who received placebo also received 3 (0-6) units of allogeneic blood products and had 700 (200-1550) ml additional blood loss; these differences were not statistically significantly different. There was one thrombotic event in each group. CONCLUSIONS: Infusion of fibrinogen concentrate triggered by Fibtem A5 ≤15 mm did not improve outcomes in PPH. Pre-specified subgroup analyses suggest that fibrinogen replacement is not required if the Fibtem A5 is > 12 mm or Clauss fibrinogen >2 g litre -1 , but an effect below these levels cannot be excluded. The raised fibrinogen at term appears to be a physiological buffer rather than required for haemostasis. TRIAL REGISTRATION: ISRCTN46295339 ( http://www.isrctn.com/ISRCTN46295339 , last accessed 5 July 2017), EudraCT 2012-005511-11 ( https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-005511-11 , last accessed 5 July 2017).
BACKGROUND: Postpartum haemorrhage (PPH) can be exacerbated by haemostatic failure. We hypothesized that early fibrinogen replacement, guided by viscoelastometric testing, reduces blood product usage and bleed size. METHODS: Women with PPH 1000-1500 ml were enrolled. If Fibtem A5 was ≤15 mm and bleeding continued, subjects were randomized to fibrinogen concentrate or placebo. The primary outcome compared the number of units of red blood cells, plasma, cryoprecipitate and platelets transfused. RESULTS: Of 663 women enrolled 55 were randomized. The adjusted incidence rate ratio (IRR) (95% CI) for the number of allogeneic units transfused in the fibrinogen group compared with placebo was 0.72 (0.3-1.7), P =0.45. In pre-specified subgroup analyses, subjects who had a Fibtem A5 ≤12 mm at the time of randomization and who received fibrinogen concentrate received a median (25th-75th centile) of 1 (0-4.5) unit of allogeneic blood products and had an additional 300 (100-350) ml blood loss whereas those who received placebo also received 3 (0-6) units of allogeneic blood products and had 700 (200-1550) ml additional blood loss; these differences were not statistically significantly different. There was one thrombotic event in each group. CONCLUSIONS: Infusion of fibrinogen concentrate triggered by Fibtem A5 ≤15 mm did not improve outcomes in PPH. Pre-specified subgroup analyses suggest that fibrinogen replacement is not required if the Fibtem A5 is > 12 mm or Clauss fibrinogen >2 g litre -1 , but an effect below these levels cannot be excluded. The raised fibrinogen at term appears to be a physiological buffer rather than required for haemostasis. TRIAL REGISTRATION: ISRCTN46295339 ( http://www.isrctn.com/ISRCTN46295339 , last accessed 5 July 2017), EudraCT 2012-005511-11 ( https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-005511-11 , last accessed 5 July 2017).
Authors: Ada Gillissen; Thomas van den Akker; Camila Caram-Deelder; Dacia D C A Henriquez; Kitty W M Bloemenkamp; Moniek P M de Maat; Jos J M van Roosmalen; Joost J Zwart; Jeroen Eikenboom; Johanna G van der Bom Journal: Blood Adv Date: 2018-10-09
Authors: Philipp Helmer; Tobias Schlesinger; Sebastian Hottenrott; Michael Papsdorf; Achim Wöckel; Magdalena Sitter; Tobias Skazel; Thomas Wurmb; Ismail Türkmeneli; Christoph Härtel; Stefan Hofer; Ibrahim Alkatout; Leila Messroghli; Thierry Girard; Patrick Meybohm; Peter Kranke Journal: Anaesthesist Date: 2022-03-04 Impact factor: 1.041
Authors: Megan Dale; Sarah F Bell; Susan O'Connell; Cerys Scarr; Kathryn James; Miriam John; Rachel E Collis; Peter W Collins; Grace Carolan-Rees Journal: Pharmacoecon Open Date: 2022-09-06
Authors: Sarah F Bell; Rachel E Collis; Philip Pallmann; Christopher Bailey; Kathryn James; Miriam John; Kevin Kelly; Thomas Kitchen; Cerys Scarr; Adam Watkins; Tracey Edey; Elinore Macgillivray; Kathryn Greaves; Ingrid Volikas; James Tozer; Niladri Sengupta; Iolo Roberts; Claire Francis; Peter W Collins Journal: BMC Pregnancy Childbirth Date: 2021-05-15 Impact factor: 3.007
Authors: Sriram Krishnaswamy; Walter Ageno; Yaseen Arabi; Tiziano Barbui; Suzanne Cannegieter; Marc Carrier; Audrey C Cleuren; Peter Collins; Laurence Panicot-Dubois; Jane E Freedman; Kathleen Freson; Philip Hogg; Andra H James; Colin A Kretz; Michelle Lavin; Frank W G Leebeek; Weikai Li; Coen Maas; Kellie Machlus; Michael Makris; Ida Martinelli; Leonid Medved; Marguerite Neerman-Arbez; James S O'Donnell; Jamie O'Sullivan; Madhvi Rajpurkar; Verena Schroeder; Paul Clinton Spiegel; Simon J Stanworth; Laura Green; Anetta Undas Journal: Res Pract Thromb Haemost Date: 2021-07-16
Authors: Derek S Sim; Cornell R Mallari; John M Teare; Richard I Feldman; Maxine Bauzon; Terry W Hermiston Journal: Res Pract Thromb Haemost Date: 2021-06-30